242 related articles for article (PubMed ID: 32100957)
1. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.
Yin Z; Wang W; Qu G; Wang L; Wang X; Pan Q
Thorac Cancer; 2020 Apr; 11(4):956-963. PubMed ID: 32100957
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
Wang Y; Wei Y; Fan X; Zhang P; Wang P; Cheng S; Zhang J
Thorac Cancer; 2020 Jun; 11(6):1613-1620. PubMed ID: 32291953
[TBL] [Abstract][Full Text] [Related]
3. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract][Full Text] [Related]
4. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3.
Zhou Y; Chen Y; Ding W; Hua Z; Wang L; Zhu Y; Qian H; Dai T
IUBMB Life; 2018 Apr; 70(4):276-290. PubMed ID: 29500870
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-96-5p contributed to the proliferation of gastric cancer cells by targeting FOXO3.
He X; Zou K
J Biochem; 2020 Jan; 167(1):101-108. PubMed ID: 31598681
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ-Foxo3 inhibits esophageal squamous cell cancer progression via the miR-23a/PTEN axis.
Xing Y; Zha WJ; Li XM; Li H; Gao F; Ye T; Du WQ; Liu YC
J Cell Biochem; 2020 Mar; 121(3):2595-2605. PubMed ID: 31680314
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
[TBL] [Abstract][Full Text] [Related]
8. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
Salem M; Shan Y; Bernaudo S; Peng C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis.
Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B
Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract][Full Text] [Related]
12. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
13. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
[TBL] [Abstract][Full Text] [Related]
15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
16. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
18. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.
Li J; Li P; Chen T; Gao G; Chen X; Du Y; Zhang R; Yang R; Zhao W; Dun S; Gao F; Zhang G
Tumour Biol; 2015 Feb; 36(2):685-92. PubMed ID: 25286764
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
20. miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.
Nie W; Ni D; Ma X; Zhang Y; Gao Y; Peng C; Zhang X
Int J Oncol; 2019 Feb; 54(2):559-571. PubMed ID: 30483771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
